Profile data is unavailable for this security.
About the company
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
- Revenue in CNY (TTM)2.33bn
- Net income in CNY-62.99m
- Incorporated1998
- Employees2.50k
- LocationJoinn Laboratories China Co LtdA5 Rongjing East StreetEconomic-Technological Development AreaBEIJING 100176ChinaCHN
- Phone+86 1 067869582
- Fax+86 1 067869966
- Websitehttps://www.joinnlabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Runda Medical Technology Co Ltd | 9.04bn | 214.86m | 9.73bn | 3.32k | 43.70 | 2.25 | -- | 1.08 | 0.3719 | 0.3719 | 15.65 | 7.22 | 0.6219 | 4.66 | 1.56 | 2,727,524.00 | 2.55 | 4.78 | 7.04 | 12.86 | 26.02 | 27.13 | 4.10 | 6.36 | 1.06 | 7.84 | 0.5568 | 12.43 | -12.84 | 8.93 | -34.58 | 0.8514 | 3.88 | 1.03 |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 4.87bn | 543.34m | 9.84bn | 5.44k | 18.11 | 1.83 | -- | 2.02 | 0.9342 | 0.9342 | 8.39 | 9.22 | 0.6915 | 3.50 | 6.92 | 895,523.30 | 7.82 | 6.68 | 10.54 | 9.49 | 72.55 | 74.02 | 11.31 | 10.28 | 2.23 | -- | 0.00 | 25.57 | 11.88 | 4.94 | 23.54 | 5.33 | -1.87 | 35.99 |
| Joinn Laboratories China Co Ltd | 2.33bn | -62.99m | 10.23bn | 2.50k | -- | 1.38 | -- | 4.39 | -0.0862 | -0.0862 | 3.12 | 10.75 | 0.23 | 0.6906 | 8.14 | -- | -0.6856 | 8.99 | -0.8219 | 11.07 | 39.46 | 46.76 | -2.98 | 32.01 | 3.51 | 0.9996 | 0.0079 | 23.79 | 4.78 | 42.20 | -63.04 | 29.66 | 8.21 | 23.46 |
| Bio-Thera Solutions Ltd | 711.46m | -370.90m | 10.33bn | 1.17k | -- | 9.45 | -- | 14.52 | -0.8957 | -0.8957 | 1.72 | 2.64 | 0.3099 | 0.9439 | 6.06 | 609,647.70 | -16.15 | -23.62 | -23.70 | -30.81 | 71.41 | 79.76 | -52.13 | -106.72 | 0.8258 | -367.55 | 0.3515 | -- | 54.86 | -- | 17.87 | -- | -3.78 | -- |
| Sansure Biotech Inc | 1.20bn | 384.73m | 10.68bn | 2.01k | 28.15 | 1.42 | -- | 8.88 | 0.6448 | 0.6448 | 2.06 | 12.77 | 0.1377 | 0.8274 | 1.41 | 599,646.90 | 4.14 | 26.74 | 4.69 | 30.97 | 74.82 | 67.47 | 30.06 | 42.01 | 7.94 | -- | 0.0589 | 22.40 | -84.39 | 27.12 | -81.22 | 121.89 | 64.08 | -- |
| Liaoning Chengda Biotechnology Co Ltd | 1.76bn | 420.34m | 10.91bn | 1.73k | 25.84 | 1.12 | -- | 6.19 | 1.01 | 1.01 | 4.26 | 23.41 | 0.1743 | 0.7061 | 1.61 | 1,016,911.00 | 4.16 | 10.63 | 4.27 | 11.01 | 81.48 | 85.74 | 23.87 | 39.56 | 20.80 | -- | 0.002 | 31.53 | -3.58 | 4.71 | -34.75 | -5.56 | 39.78 | -- |
Data as of Jun 14 2024. Currency figures normalised to Joinn Laboratories China Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
9.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Harvest Fund Management Co., Ltd.as of 28 Mar 2024 | 16.32m | 2.59% |
| Hwabao WP Fund Management Co., Ltd.as of 28 Mar 2024 | 10.71m | 1.70% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 7.78m | 1.23% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 6.44m | 1.02% |
| APG Asset Management NVas of 31 Dec 2022 | 4.09m | 0.65% |
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 3.44m | 0.55% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 2.68m | 0.43% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 2.30m | 0.37% |
| Tian Hong Asset Management Co., Ltd.as of 31 Dec 2023 | 2.25m | 0.36% |
| The Vanguard Group, Inc.as of 06 Jun 2024 | 1.94m | 0.31% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
